☆ 4.8 Editorial Material

A regulatory challenge for natural language processing (NLP)-based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Journal

CLINICAL AND TRANSLATIONAL MEDICINE

Volume 13, Issue 8, Pages -

Publisher

JOHN WILEY & SONS LTD

DOI: 10.1002/ctm2.1362

Keywords

artificial intelligence; ChatGPT; healthcare decisions; natural language processing (NLP); regulatory approval; software as medical device (SaMD)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

A regulatory challenge for natural language processing (NLP)-based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?

Journal

CLINICAL AND TRANSLATIONAL MEDICINE

Publisher

JOHN WILEY & SONS LTD

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

A regulatory challenge for natural language processing (NLP)-based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?

Journal

CLINICAL AND TRANSLATIONAL MEDICINE

Publisher

JOHN WILEY & SONS LTD

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper